Characteristic | All Patients (n = 17) | Adult Patients (n = 8) | Pediatric Patients (n = 9) |
---|---|---|---|
Median age at treatment, years (range) | 14 (1–68) | 47 (25–68) | 9 (1–14) |
Gender | |||
Female | 13 (76%) | 8 (100%) | 5 (56%) |
Male | 4 (24%) | 0 (0%) | 4 (44%) |
Diagnosis | |||
Chordoma | 1 (6%) | 1 (13%) | 0 (0%) |
Chondrosarcoma | 6 (35%) | 6 (75%) | 0 (0%) |
Craniopharyngioma | 3 (18%) | 1 (13%) | 0 (0%) |
Osteoblastoma | 1 (6%) | 0 (0%) | 3 (33%) |
Medulloblastoma | 2 (12%) | 0 (0%) | 2 (22%) |
Nongerminomatous germ cell tumor | 2 (12%) | 0 (0%) | 2 (22%) |
Ependymoma | 1 (6%) | 0 (0%) | 1 (11%) |
Rhabdomyosarcoma | 1 (6%) | 0 (0%) | 1 (11%) |
Referral location | |||
Jacksonville, FL | 8 (47%) | 0 (0%) | 8 (89%) |
Boston, MA | 5 (29%) | 5 (63%) | 0 (0%) |
Loma Linda, CA | 3 (18%) | 3 (38%) | 0 (0%) |
Memphis, TN | 1 (6%) | 0 (0%) | 1 (11%) |
Treatment Year | |||
2009–2013 | 5 (29%) | 4 (50%) | 1 (11%) |
2014–2018 | 12 (71%) | 4 (50%) | 8 (89%) |
Median number of fractions (range) | 33 (20–40) | 37 (35–40) | 30 (20–33) |
Median length of stay in US, days (range) | 61 (44–81) | 65 (52–81) | 56 (44–62) |